Open AccessEffects of transgenically produced recombinant human antithrombin on activated clotting times
Author(s) -
Toshiaki Mochizuki,
Jones Mf,
J Lévy
Publication year - 1998
Publication title -
anesthesia and analgesia/anesthesia and analgesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.404
H-Index - 201
eISSN - 1526-7598
pISSN - 0003-2999
DOI - 10.1213/00000539-199804001-00064
Subject(s) - medicine , activated clotting time , heparin , cardiopulmonary bypass , antithrombin , dosing , thrombin , recombinant dna , anesthesia , clotting time , whole blood , pharmacology , platelet , biochemistry , gene , chemistry